PA
EYE icon

PharVision Advisers’s National Vision EYE Stock Holding History

PharVision Advisers’s Portfolio EYE Stock Details EYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,216
Closed -$315K – 290
2025
Q4 		$315K Buy
12,216
+1,975
+19% +$53.1K 0.16% 242
2025
Q3 		$299K Buy
+10,241
New +$252K 0.17% 228

Other funds holding EYE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PharVision Advisers's EYE Position: Q1 2026 in Review

PharVision Advisers sold out of National Vision (EYE) in Q1 2026, closing a stake of 12,216 shares — an estimated $315K sold.

PharVision Advisers first reported a position in EYE in Q3 2025 and held it in 2 quarters. The position peaked at $315K in Q4 2025. 257 funds tracked by Wall St. Rank hold EYE as of Q1 2026.

  • PharVision Advisers reported no remaining National Vision position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,216 National Vision shares in Q1 2026, an estimated $315K.
  • PharVision Advisers first reported a position in National Vision in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's National Vision position peaked at $315K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held National Vision as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.